Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients

Table 1 Clinicopathologic characteristics of 104 patients with UICC stage II–III colorectal cancer (comprising non-early relapsed and early relapsed patients)

Variables	Non-early relapsed^a (N = 54)	Early relapsed^a (N = 50)	P value
Age (<65/≥65 year)	19/35	23/27	0.261
Gender (F/M)	20/34	20/30	0.756
UICC^a stage (II/III)	34/20	20/30	0.019
Depth of invasion (T₁/T₂/T₃/T₄)	0/2/45/7	0/1/43/6	0.857
Maximum size (<5/≥5 cm)	28/26	25/25	0.850
Location (colon/rectum)	48/6	28/22	0.0001
Vascular invasion (N/Y)	46/8	30/20	0.003
Perineural invasion (N/Y)	46/8	31/19	0.007
Lymph node metastasis [N(−)/N(+)]	34/20	20/30	0.019
Type of tumor (A/M)	52/2	42/8	0.029
Histology (WD/MD/PD)	1/45/8	0/44/6	0.465

	Mean ± SD	Mean ± SD	P value
Age	66.50 ± 12.05	65.10 ± 14.43	0.594

UICC Union for international cancer control, A adenocarcinoma, M mucinous carcinoma, WD well differentiated, MD moderately well differentiated, PD poorly differentiated
^aEarly relapse is defined as cancer recurrence within 12 months after surgery

ISSN: 1479-5876